Penumbra, Inc. (PEN) · page 58 of 61
The table segments peers by FDA pathway (PMA vs 510K) to highlight that PEN is trading at multiples inconsistent with its lower-tier 510K status and weaker fundamentals.
Activist deck · peer_benchmark · compare_peers · dense density
Slide locked Sign in to view
Slide schematic 4/4
paragraph 1/1 source-note 1/1 table 1/1 title 1/1
Components 4
paragraph source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1